Literature DB >> 19906310

Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance.

Javier E Lopez1, Khung Yeo, Gary Caputo, Michael Buonocore, Saul Schaefer.   

Abstract

Methamphetamine is known to cause a cardiomyopathy which may be reversible with appropriate medical therapy and cessation of use. Late gadolinium enhancement cardiovascular magnetic resonance (CMR) has been shown to identify fibrosis in ischemic and non-ischemic cardiomyopathies. We present a case of severe methamphetamine-associated cardiomyopathy in which cardiac function recovered after 6 months. Evaluation by CMR using late gadolinium enhancement was notable for an absence of enhancement, suggesting an absence of irreversible myocyte injury and a good prognosis. CMR may be useful to predict recovery in toxin-associated non-ischemic cardiomyopathies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906310      PMCID: PMC2780987          DOI: 10.1186/1532-429X-11-46

Source DB:  PubMed          Journal:  J Cardiovasc Magn Reson        ISSN: 1097-6647            Impact factor:   5.364


  20 in total

1.  Acute coronary syndrome and crystal methamphetamine use: a case series.

Authors:  Mevan Wijetunga; Romal Bhan; Joseph Lindsay; Steven Karch
Journal:  Hawaii Med J       Date:  2004-01

2.  Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module).

Authors:  Deborah B Diercks; Gregg C Fonarow; J Douglas Kirk; Preeti Jois-Bilowich; Judd E Hollander; Jim Edward Weber; Janet Wynne; Roger M Mills; Clyde Yancy; W Franklin Peacock
Journal:  Am J Cardiol       Date:  2008-09-05       Impact factor: 2.778

3.  Cardiac muscle lesions associated with chronic administration of methamphetamine in rats.

Authors:  S Y He; R Matoba; N Fujitani; K Sodesaki; S Onishi
Journal:  Am J Forensic Med Pathol       Date:  1996-06       Impact factor: 0.921

4.  Reversible dilated cardiomyopathy induced by methamphetamine.

Authors:  L J Jacobs
Journal:  Clin Cardiol       Date:  1989-12       Impact factor: 2.882

5.  Methamphetamine induces an increase in cell size and reorganization of myofibrils in cultured adult rat cardiomyocytes.

Authors:  Y Maeno; M Iwasa; H Inoue; H Koyama; R Matoba
Journal:  Int J Legal Med       Date:  2000       Impact factor: 2.686

6.  Cardiac lesions and their reversibility after long term administration of methamphetamine.

Authors:  M N Islam; H Kuroki; B Hongcheng; Y Ogura; N Kawaguchi; S Onishi; C Wakasugi
Journal:  Forensic Sci Int       Date:  1995-08-28       Impact factor: 2.395

7.  Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.

Authors:  David Bello; Dipan J Shah; George M Farah; Silvia Di Luzio; Michele Parker; Maryl R Johnson; William G Cotts; Francis J Klocke; Robert O Bonow; Robert M Judd; Mihai Gheorghiade; Raymond J Kim
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

8.  Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use.

Authors:  Samuel D Turnipseed; John R Richards; J Douglas Kirk; Deborah B Diercks; Ezra A Amsterdam
Journal:  J Emerg Med       Date:  2003-05       Impact factor: 1.484

9.  Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.

Authors:  J A McCrohon; J C C Moon; S K Prasad; W J McKenna; C H Lorenz; A J S Coats; D J Pennell
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

10.  Cardiomyopathy associated with the smoking of crystal methamphetamine.

Authors:  R Hong; E Matsuyama; K Nur
Journal:  JAMA       Date:  1991-03-06       Impact factor: 56.272

View more
  10 in total

Review 1.  A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy.

Authors:  Michael Osekowski; Adam Trytell; Andre La Gerche; David Prior; Andrew MacIsaac; Elizabeth D Paratz
Journal:  Am J Cardiovasc Drugs       Date:  2022-02-14       Impact factor: 3.283

Review 2.  [Cardiomyopathy in a 22-year-old man with a long history of methamphetamine abuse].

Authors:  D M Schwab; H A Katus; P W Raake
Journal:  Internist (Berl)       Date:  2019-03       Impact factor: 0.743

Review 3.  Review of Journal of Cardiovascular Magnetic Resonance 2009.

Authors:  D J Pennell; D N Firmin; P J Kilner; W J Manning; R H Mohiaddin; S Neubauer; S K Prasad
Journal:  J Cardiovasc Magn Reson       Date:  2010-03-19       Impact factor: 5.364

Review 4.  Methamphetamine-associated cardiomyopathy.

Authors:  Sekon Won; Robert A Hong; Ralph V Shohet; Todd B Seto; Nisha I Parikh
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

Review 5.  Review of journal of cardiovascular magnetic resonance 2010.

Authors:  Dudley J Pennell; David N Firmin; Philip J Kilner; Warren J Manning; Raad H Mohiaddin; Sanjay K Prasad
Journal:  J Cardiovasc Magn Reson       Date:  2011-09-13       Impact factor: 5.364

6.  Uncharted waters: rare and unclassified cardiomyopathies characterized on cardiac magnetic resonance imaging.

Authors:  Ailbhe C O'Neill; Shaunagh McDermott; Carole A Ridge; Kenneth McDonald; David Keane; Jonathan D Dodd
Journal:  Insights Imaging       Date:  2010-10-19

7.  Point-of-Care Ultrasound Identifies Decompensated Heart Failure in a Young Male with Methamphetamine-Associated Cardiomyopathy Presenting in Severe Sepsis to the Emergency Department.

Authors:  David Kinas; Michael Dalley; Kayla Guidry; Mark A Newberry; David A Farcy
Journal:  Case Rep Emerg Med       Date:  2018-10-09

8.  Sex influences susceptibility to methamphetamine cardiomyopathy in mice.

Authors:  Marie C Marcinko; April L Darrow; Aaron J Tuia; Ralph V Shohet
Journal:  Physiol Rep       Date:  2019-03

Review 9.  Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review.

Authors:  Pavan K V Reddy; Tien M H Ng; Esther E Oh; Gassan Moady; Uri Elkayam
Journal:  J Am Heart Assoc       Date:  2020-05-29       Impact factor: 5.501

Review 10.  Methamphetamine-related cardiovascular diseases.

Authors:  Valentin Schwarzbach; Karsten Lenk; Ulrich Laufs
Journal:  ESC Heart Fail       Date:  2020-01-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.